Patients taking newer blood pressure drugs have a decreased risk of developing diabetes, according to an analysis of the biggest clinical trial in Europe. The study found that only 8 percent of the people on newer medicines developed diabetes as against 11.4 percent of those on older drugs.
The study involved 19,000 people. The study compared drugs like Norvasc and Coversyl with a beta-blocker and a diuretic. Norvasc is amlodipine, while Coversyl is perindopril. Professor Peter Sever of Imperial College in London, co-chairman of the study, said the findings underlined the fact that beta-blockers were no longer effecting in treating blood pressure.